Search Press releases

Press releases teaser image
22 Oct 2024

UCB Announces Bepranemab Phase 2a Study Results Accepted for Late-Breaking Presentation at Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting

Read More
Press releases teaser image
14 Oct 2024

UCB receives U.S. FDA approval for 320 mg single-injection device presentations of BIMZELX[®] (bimekizumab-bkzx)

Read More
Press releases teaser image
11 Oct 2024

UCB showcases new data for gMG management at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and MGFA Scientific Session

Read More
Press releases teaser image
10 Oct 2024

Transparency notification BlackRock, Inc.

Read More
Press releases teaser image
9 Oct 2024

Transparency notification BlackRock, Inc.

Read More
Press releases teaser image
3 Oct 2024

Transparency notification BlackRock, Inc.

Read More

Stay up-to-date on the latest news and information from UCB